secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0000950170-25-086292
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRIDEX stockholders approve doubling authorized shares to 63.5M and 1M share increase in equity plan
--------------------------------------------------------------------------------

- Authorized common stock increased from 30M to 63.5M shares; Restated Charter effective June 11, 2025.
- 2008 Equity Incentive Plan amended: reserve increased by 1M shares (total 6.85M), term extended to June 11, 2035.
- Stockholders approved removal of 19.99% issuance limit for conversion of Series B Preferred and $4M note held by Novel.
- All director nominees elected; BPM LLP ratified as auditor for FY2026; say-on-pay approved with one-year frequency.
- Series B Preferred (600k shares) voted in favor of all proposals; common vote percentages ranged 80-92% for director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000095017025086292/0000950170-25-086292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000095017025086292/irix-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer